Melkersson-Rosenthal syndrome

Genetic MONDO:0007969 Granulomatous disease Autoinflammatory syndrome

Ask OpenScientist

Ask a research question about Melkersson-Rosenthal syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

3
Pathophys.
4
Phenotypes
4
Genes
5
Medical Actions
3
Differentials
6
References
2
Deep Research
⚙

Pathophysiology

3
Non-caseating granulomatous inflammation with epithelioid histiocytes
Melkersson-Rosenthal syndrome is characterized by non-caseating granulomatous inflammation of orofacial tissues with epithelioid macrophages, multinucleated giant cells, and perivascular/perineural lymphocytic infiltration. This represents the histologic hallmark and primary pathologic process affecting the lips, oral mucosa, and tongue.
epithelioid macrophage CL:0002150 T lymphocyte CL:0000084
granuloma formation GO:0034612 leukocyte migration GO:0050900
lip UBERON:0001833 oral mucosa UBERON:0003729 tongue UBERON:0001723
Show evidence (2 references)
PMID:39135018 SUPPORT
"Melkersson-Rosenthal syndrome (MRS) is a rare neuro-mucocutaneous disorder characterized by recurrent edema, facial palsies, and nerve dysfunctions often associated with the plicata tongue."
Establishes the clinical phenotype and neuromucocutaneous involvement characteristic of MRS
PMID:30627963 SUPPORT
"Granulomatous lesions of the orofacial region are a heterogeneous group of disorders characterized by a granulomatous reaction to a variety of stimuli."
Provides context for the granulomatous nature of orofacial pathology including MRS
Dysregulated Th1/Th17 cytokine signaling with IL-12/23 and TNF-α involvement
The granulomatous inflammation in MRS is driven by dysregulated Th1/Th17 cytokine axes involving TNF-α, IFN-γ, and IL-12/23 signaling. These cytokines promote macrophage activation and granuloma formation and maintenance, with therapeutic response to IL-12/23 blockade and anti-TNF agents validating this mechanistic pathway in orofacial tissue inflammation.
epithelioid macrophage CL:0002150
response to tumor necrosis factor GO:0034612 interferon-gamma-mediated signaling pathway GO:0060333
oral mucosa UBERON:0003729
Show evidence (1 reference)
PMID:32782477 SUPPORT
"IL-12 and IL-23 are linked to the production of IFN-γ, a pivotal mediator of inflammation in peripheral tissues, including orofacial mucosa, by promoting multiple proinflammatory cytokines."
Identifies the IL-12/23 and IFN-γ cytokine pathways implicated in orofacial granulomatous inflammation
Lymphatic dysfunction with intralymphatic histiocytosis and persistent edema
Lymphatic dysfunction with intralymphatic histiocytosis characterized by dilated lymphatic channels with D2-40/podoplanin-positive endothelium and intraluminal CD68-positive histiocytes contributes to sustained edema. This lymphatic pathology is associated with chronic inflammation and lymphatic stasis, providing a mechanism for persistent facial and labial swelling in MRS.
endothelial cell of lymphatic vessel CL:0002138
lymphatic vessel development GO:0001945
lymphatic vessel UBERON:0001473
Show evidence (1 reference)
PMID:32782477 SUPPORT
"IL-12 and IL-23 are linked to the production of IFN-γ, a pivotal mediator of inflammation in peripheral tissues, including orofacial mucosa, by promoting multiple proinflammatory cytokines."
Supports the lymphatic dysfunction mechanism through inflammatory cytokine effects on endothelial function
●

Phenotypes

4
Head and Neck 3
Recurrent facial edema VERY_FREQUENT Facial edema HP:0000282
Show evidence (2 references)
PMID:39135018 SUPPORT
"recurrent edema, facial palsies, and nerve dysfunctions often associated with the plicata tongue"
Confirms recurrent facial edema as a characteristic phenotype of MRS
PMID:31466978 SUPPORT
"he presented the classic triad of Melkersson-Rosenthal syndrome which includes recurrent orofacial oedema, facial nerve palsy and fissured tongue"
Establishes recurrent orofacial edema as part of the classic clinical triad
Facial paralysis VERY_FREQUENT Facial paralysis HP:0007209
Show evidence (2 references)
PMID:31466978 SUPPORT
"recurrent facial nerve palsy since the age of 10 years"
Documents the recurrent nature of facial nerve paralysis in MRS patients
PMID:40255708 SUPPORT
"CG can occur as an isolated condition or as part of Melkersson-Rosenthal syndrome, which also includes facial paralysis and a fissured tongue"
Confirms facial paralysis as a component of the MRS triad
Lingual swelling and macroglossia VERY_FREQUENT Macroglossia HP:0000158
Show evidence (2 references)
PMID:31466978 SUPPORT
"Physical examination revealed lip swelling and lingua plicata. Thus, he presented the classic triad of Melkersson-Rosenthal syndrome"
Confirms fissured tongue (lingua plicata) as part of the classic MRS triad
PMID:40255708 SUPPORT
"Melkersson-Rosenthal syndrome, which also includes facial paralysis and a fissured tongue"
Establishes lingual swelling as a key phenotype of MRS
Nervous System 1
Migraine VERY_RARE Migraine HP:0002076
Show evidence (1 reference)
PMID:37510386 PARTIAL
"Migraine is a common neurological disorder... A family in which two sisters displayed recurrent migraines, one of which presented recurrent facial palsy and had clinical diagnosis of MRS."
Documents rare association of migraine with MRS in a family with SCN1A variants, suggesting potential genetic overlap
🧬

Genetic Associations

4
TNF-α pathway involvement
Show evidence (1 reference)
PMID:32782477 SUPPORT
"Reported evidence indicates treatment with an anti-TNF agent (mainly infliximab) is the most recommended therapeutic option after failure of conventional treatments."
Demonstrates TNF-α involvement in MRS through effective therapeutic targeting with anti-TNF agents
IFN-γ pathway involvement in autoimmune/allergic context
Show evidence (1 reference)
PMID:31466978 PARTIAL
"interferon gamma could play a key role. To our knowledge, this is the first case report in which Melkersson-Rosenthal syndrome has been observed concurrently with coeliac disease."
Implicates IFN-γ as a central mediator linking MRS to autoimmune and allergic pathways
IL-12/IL-23 signaling pathway
Show evidence (1 reference)
PMID:32782477 SUPPORT
"IL-12 and IL-23 are linked to the production of IFN-γ, a pivotal mediator of inflammation in peripheral tissues, including orofacial mucosa, by promoting multiple proinflammatory cytokines."
Establishes IL-12/23 signaling as a central pathway driving IFN-γ production and orofacial granulomatous inflammation
SCN1A variants in rare phenotypes
Show evidence (1 reference)
PMID:37510386 PARTIAL
"MRS is a disorder with variable expressivity and clinical as well as genetic heterogeneity; however, the causative gene remains to be identified... We identified a c.3521C>G missense heterozygous variant in SCN1A carried only by the affected sister."
Documents rare SCN1A variant association in an MRS patient with facial palsy and migraine, suggesting genetic heterogeneity in MRS pathogenesis
💊

Medical Actions

5
Intralesional corticosteroid injection
Action: corticosteroid injection Ontology label: corticosteroid agent therapy MAXO:0000640
Agent: triamcinolone CHEBI:9667
Direct injection of corticosteroids (triamcinolone) into affected facial tissues reduces inflammatory response and edema, providing temporary relief lasting weeks to months during acute exacerbations.
Show evidence (1 reference)
PMID:32782477 SUPPORT
"Oral or locally injected corticosteroids (triamcinolone) are the initial therapeutic option."
Establishes intralesional corticosteroid injection as first-line therapy for MRS-associated granulomatous cheilitis
Systemic corticosteroids
Action: corticosteroid therapy Ontology label: corticosteroid agent therapy MAXO:0000640
Oral corticosteroids used during acute exacerbations of facial edema and paralysis to suppress inflammatory response.
Show evidence (1 reference)
PMID:39135018 SUPPORT
"A comprehensive diagnosis and multidisciplinary treatment approach including surgery, local injections, and oral medication were implemented, resulting in a favorable prognosis."
Supports the use of systemic medication (oral corticosteroids) as part of multidisciplinary MRS management
Anti-TNF therapy (infliximab)
Action: immunosuppressive therapy Ontology label: Pharmacotherapy NCIT:C15986
Agent: infliximab NCIT:C1789
TNF-α antagonist effective in refractory MRS cases when conventional therapies fail. Infliximab targets TNF-α-driven granulomatous inflammation, though response may vary and some patients progress to IL-12/23 blockade.
Show evidence (1 reference)
PMID:32782477 SUPPORT
"Reported evidence indicates treatment with an anti-TNF agent (mainly infliximab) is the most recommended therapeutic option after failure of conventional treatments."
Establishes infliximab as a validated TNF-α blockade strategy for refractory granulomatous cheilitis
Anti-IL-12/23 therapy (ustekinumab)
Action: immunosuppressive therapy Ontology label: Pharmacotherapy NCIT:C15986
Agent: monoclonal antibody NCIT:C20401
Biologic monoclonal antibody targeting IL-12/23 pathway, effective in severe refractory cases unresponsive to anti-TNF therapy. Suppresses the underlying Th1/Th17 cytokine-driven granulomatous inflammation and has demonstrated sustained remission in MRS-associated orofacial granulomas.
Show evidence (1 reference)
PMID:32782477 SUPPORT
"ustekinumab, a monoclonal antibody against interleukins 12/23, with proven efficacy in CD and psoriasis, is attractive. The present study is the second to report on the effectiveness of ustekinumab for inducing remission of severe and recurrent granulomatous cheilitis in patients with CD."
Demonstrates efficacy of IL-12/23 blockade in treating refractory MRS-associated granulomatous cheilitis
Supportive care
Action: supportive care MAXO:0000950
Eye care for facial paralysis to prevent corneal damage, speech and swallowing management for lingual involvement, and psychological support for cosmetic and functional impacts.
Show evidence (1 reference)
PMID:39135018 SUPPORT
"A comprehensive diagnosis and multidisciplinary treatment approach including surgery, local injections, and oral medication were implemented, resulting in a favorable prognosis."
Emphasizes the importance of multidisciplinary supportive care in MRS management
🌍

Environmental Factors

1
Immune and allergic triggers
Episodes of facial edema may be triggered by stress, infection, allergic exposures, or food ingestion with individual patient triggers varying. Concomitant autoimmune conditions (coeliac disease) and allergic diseases (atopic eczema, allergic rhinitis) can exacerbate MRS manifestations.
Show evidence (2 references)
PMID:31466978 SUPPORT
"he exhibited recurrent facial nerve palsy since the age of 10 years, coeliac disease since the age of 12 years, atopic eczema, allergic rhinitis and asthma."
Demonstrates associations between MRS and autoimmune/allergic conditions as potential environmental/triggering factors
PMID:40255708 PARTIAL
"Laboratory findings were significant for Saccharomyces and Lyme disease, while other autoimmune biomarkers remained negative"
Suggests potential infectious triggers (yeast, Borrelia burgdorferi) in CG/MRS pathogenesis
🔬

Biochemical Markers

3
TNF-α elevation (Elevated)
Context: Serum and orofacial tissue marker of granulomatous inflammation
Show evidence (1 reference)
PMID:32782477 SUPPORT
"Reported evidence indicates treatment with an anti-TNF agent (mainly infliximab) is the most recommended therapeutic option after failure of conventional treatments."
Demonstrates the role of TNF-α in MRS pathophysiology through effective therapeutic targeting with TNF antagonists
Interferon-gamma (IFN-γ) elevation (Elevated)
Context: Th1-derived cytokine promoting macrophage activation and granuloma formation
Show evidence (1 reference)
PMID:31466978 PARTIAL
"interferon gamma could play a key role. To our knowledge, this is the first case report in which Melkersson-Rosenthal syndrome has been observed concurrently with coeliac disease."
Implicates IFN-γ elevation in MRS pathophysiology, particularly in association with autoimmune and allergic conditions
IL-12 and IL-23 (Elevated)
Context: Th1/Th17-promoting cytokines in orofacial granulomas
Show evidence (1 reference)
PMID:32782477 SUPPORT
"IL-12 and IL-23 are linked to the production of IFN-γ, a pivotal mediator of inflammation in peripheral tissues, including orofacial mucosa, by promoting multiple proinflammatory cytokines."
Establishes IL-12/23 elevation as part of the inflammatory cytokine cascade in orofacial granulomatous inflammation
🔀

Differential Diagnoses

3

Conditions with similar clinical presentations that must be differentiated from Melkersson-Rosenthal syndrome:

Crohn's disease with orofacial manifestations MONDO:0005011
Overlapping Features Oral Crohn disease (OCD) and orofacial granulomatosis (OFG) present with non-caseating granulomatous inflammation histologically indistinguishable from MRS. However, Crohn's disease has significant gastrointestinal involvement (terminal ileum, colon) whereas MRS is primarily limited to orofacial structures.
Distinguishing Features
  • Crohn's disease has significant gastrointestinal involvement; MRS is primarily orofacial
  • Histologic overlap but clinical differentiation via systemic evaluation and GI symptoms
Show evidence (2 references)
PMID:30627963 SUPPORT
"Secondary causes of granulomas include infectious agents, sarcoid, and Crohn disease."
Establishes Crohn disease as a key differential diagnosis for orofacial granulomatosis including MRS
PMID:32782477 SUPPORT
"OFG can occur as an isolated phenomenon or as a manifestation of CD, called oral CD (OCD)."
Highlights the relationship between orofacial granulomatosis and Crohn disease, and the need for clinical/histologic differentiation
Sarcoidosis MONDO:0019338
Overlapping Features Sarcoidosis can cause facial swelling and non-caseating granulomatous inflammation but presents as a systemic multiorgan disease with pulmonary and lymph node involvement, distinct from the primarily orofacial involvement in MRS. Sarcoidosis typically lacks recurrent facial nerve paralysis as a primary manifestation.
Distinguishing Features
  • Sarcoidosis is systemic with pulmonary and hilar lymphadenopathy involvement; MRS is primarily orofacial
  • Sarcoidosis lacks recurrent facial nerve paralysis as primary feature
  • Sarcoidosis has systemic symptoms and elevated ACE levels
Show evidence (1 reference)
PMID:40255708 SUPPORT
"Cheilitis granulomatosa (CG) is a persistent and progressive swelling of the lips that can be non-tender and soft or firm to touch, with noncaseating granulomas that are perilymphatic and may show intralymphatic histiocytosis and lymphatic dilatation."
Describes CG/MRS distinguishing features including intralymphatic histiocytosis that helps differentiate from systemic sarcoidosis
Bell's palsy MONDO:0005665
Overlapping Features Bell's palsy presents with acute facial paralysis but lacks the chronic recurrent orofacial edema and granulomatous histopathology characteristic of MRS. Bell's palsy typically resolves within weeks whereas MRS has chronic relapsing course with persistent granulomatous changes between episodes.
Distinguishing Features
  • Bell's palsy is acute/subacute with resolution within weeks; MRS has chronic relapsing course
  • Bell's palsy lacks orofacial edema and granulomatous inflammation on biopsy
  • MRS presents with the classic triad (edema, facial paralysis, fissured tongue)
Show evidence (1 reference)
PMID:31466978 SUPPORT
"he presented the classic triad of Melkersson-Rosenthal syndrome which includes recurrent orofacial oedema, facial nerve palsy and fissured tongue. A lip biopsy confirmed our clinical diagnosis."
Highlights that histopathologic confirmation (non-caseating granulomas) and presence of all three triad features differentiate MRS from isolated Bell's palsy
{ }

Source YAML

click to show 
name: Melkersson-Rosenthal syndrome
creation_date: '2026-01-20T22:43:10Z'
updated_date: '2026-02-17T21:53:14Z'
category: Genetic
disease_term:
  preferred_term: Melkersson-Rosenthal syndrome
  term:
    id: MONDO:0007969
    label: Melkersson-Rosenthal syndrome
parents:
- Granulomatous disease
- Autoinflammatory syndrome
prevalence:
- population: Global reported populations
  percentage: Unknown
  notes: >-
    No population-based prevalence study was identified. PubMed literature
    consistently describes Melkersson-Rosenthal syndrome as rare, and even large
    biopsy-confirmed series remain limited in size.
  evidence:
  - reference: PMID:1524274
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Melkersson-Rosenthal syndrome (MRS) has been described as a rare disease.
    explanation: >-
      This clinical review explicitly characterizes MRS as a rare disease,
      supporting an unknown but low prevalence designation.
  - reference: PMID:22836908
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Large case series including treatment are limited.
    explanation: >-
      This retrospective biopsy-confirmed series explicitly notes that large
      case series are limited, supporting the absence of a robust
      population-based prevalence estimate.
epidemiology:
- name: Age of Onset
  description: Typical age range for Melkersson-Rosenthal syndrome presentation
  minimum_value: 14
  maximum_value: 39
  mean_range: Second decade of life (10-20 years)
  unit: years
  notes: >
    Mean onset frequently in the second decade. However, cases have been reported
    across a wide age range from childhood to adulthood.
    The classic triad may not be fully apparent at disease onset, leading to delayed
    diagnosis.
  evidence:
  - reference: PMID:31466978
    reference_title: "Melkersson-Rosenthal syndrome with coeliac and allergic diseases."
    supports: SUPPORT
    snippet: "he exhibited recurrent facial nerve palsy since the age of 10 years"
    explanation: "Documents MRS onset in childhood/adolescence in a clinical case"
  - reference: PMID:36532829
    reference_title: "Peripheral facial nerve palsy in children: clinical manifestations, treatment and prognosis."
    supports: SUPPORT
    snippet: "57 children under 18 years of age diagnosed with peripheral facial nerve
      palsy at Çukurova University... categorized into many groups by etiology...
      Melkersson-Rosenthal syndrome"
    explanation: "Identifies Melkersson-Rosenthal syndrome as a recognized cause of
      facial palsy in children, establishing pediatric presentation"
  - reference: PMID:29191347
    reference_title: "Granulomatous diseases: Kids are not just little people."
    supports: SUPPORT
    snippet: "Granulomatous diseases represent a heterogeneous group of conditions
      characterized by histiocytic inflammation that affect patients of any age...
      with particular emphasis on age-related differences in the onset, epidemiology,
      clinical manifestations, prognosis"
    explanation: "Establishes that granulomatous diseases including MRS have age-related
      presentation patterns"
- name: Incidence Rate
  description: Annual incidence of Melkersson-Rosenthal syndrome in the general
    population
  minimum_value: 0.2
  maximum_value: 80
  unit: per 100,000 per year
  notes: >
    Wide variability in reported incidence rates (0.2–80 per 100,000/year) depending
    on population studied, diagnostic criteria, and case finding methodology.
    Higher rates may reflect increased awareness and diagnostic recognition. Diagnostic
    underrecognition and delayed diagnosis are common,
    particularly when only monosymptomatic variants (e.g., isolated cheilitis) are
    present.
  evidence:
  - reference: PMID:22657098
    reference_title: "Granulomatous cheilitis: a report of 6 cases and a review of the literature."
    supports: SUPPORT
    snippet: "Granulomatous cheilitis is a rare disease."
    explanation: "Establishes that MRS/granulomatous cheilitis is a rare disease with
      low population incidence"
  - reference: PMID:29191347
    reference_title: "Granulomatous diseases: Kids are not just little people."
    supports: PARTIAL
    snippet: "Granulomatous diseases represent a heterogeneous group of conditions
      characterized by histiocytic inflammation that affect patients of any age"
    explanation: "Supports that MRS as a granulomatous disease has variable epidemiology
      depending on population and recognition factors"
- name: Frequency of Complete Triad
  description: Percentage of MRS patients presenting with all three features of
    the classic triad
  minimum_value: 8
  maximum_value: 25
  unit: percent
  notes: >
    Only 8–25% of MRS cases present with the complete classic triad (recurrent orofacial
    edema, facial nerve paralysis, fissured tongue).
    Many patients present with monosymptomatic or oligosymptomatic variants, particularly
    isolated granulomatous cheilitis, leading to diagnostic delays.
  evidence:
  - reference: PMID:31466978
    reference_title: "Melkersson-Rosenthal syndrome with coeliac and allergic diseases."
    supports: SUPPORT
    snippet: "This case is particularly rare, as the classic triad is seen only in
      a minority of the cases."
    explanation: "Confirms that the complete triad occurs in only a minority of MRS
      cases"
  - reference: PMID:22657098
    reference_title: "Granulomatous cheilitis: a report of 6 cases and a review of the literature."
    supports: SUPPORT
    snippet: "Granulomatous cheilitis (Miescher cheilitis)... is the most common monosymptomatic
      form of the Melkersson-Rosenthal syndrome."
    explanation: "Demonstrates that monosymptomatic presentations (isolated cheilitis)
      are common, with only a minority presenting with the complete triad"
pathophysiology:
- name: Non-caseating granulomatous inflammation with epithelioid histiocytes
  description: >
    Melkersson-Rosenthal syndrome is characterized by non-caseating granulomatous
    inflammation of orofacial tissues with epithelioid macrophages,
    multinucleated giant cells, and perivascular/perineural lymphocytic infiltration.
    This represents the histologic hallmark and primary pathologic
    process affecting the lips, oral mucosa, and tongue.
  evidence:
  - reference: PMID:39135018
    reference_title: "A case of Melkersson-Rosenthal syndrome with temporomandibular joint osteoarthritis: multidisciplinary treatment and autoimmune etiological hypothesis."
    supports: SUPPORT
    snippet: "Melkersson-Rosenthal syndrome (MRS) is a rare neuro-mucocutaneous disorder
      characterized by recurrent edema, facial palsies, and nerve dysfunctions often
      associated with the plicata tongue."
    explanation: "Establishes the clinical phenotype and neuromucocutaneous involvement
      characteristic of MRS"
  - reference: PMID:30627963
    reference_title: "Non-infectious Granulomatous Lesions of the Orofacial Region."
    supports: SUPPORT
    snippet: "Granulomatous lesions of the orofacial region are a heterogeneous group
      of disorders characterized by a granulomatous reaction to a variety of stimuli."
    explanation: "Provides context for the granulomatous nature of orofacial pathology
      including MRS"
  cell_types:
  - preferred_term: epithelioid macrophage
    term:
      id: CL:0002150
      label: epithelioid macrophage
  - preferred_term: T lymphocyte
    term:
      id: CL:0000084
      label: T cell
  biological_processes:
  - preferred_term: granuloma formation
    term:
      id: GO:0034612
      label: response to tumor necrosis factor
  - preferred_term: leukocyte migration
    term:
      id: GO:0050900
      label: leukocyte migration
  locations:
  - preferred_term: lip
    term:
      id: UBERON:0001833
      label: lip
  - preferred_term: oral mucosa
    term:
      id: UBERON:0003729
      label: mouth mucosa
  - preferred_term: tongue
    term:
      id: UBERON:0001723
      label: tongue
- name: Dysregulated Th1/Th17 cytokine signaling with IL-12/23 and TNF-α
    involvement
  description: >
    The granulomatous inflammation in MRS is driven by dysregulated Th1/Th17 cytokine
    axes involving TNF-α, IFN-γ, and IL-12/23 signaling.
    These cytokines promote macrophage activation and granuloma formation and maintenance,
    with therapeutic response to IL-12/23 blockade and
    anti-TNF agents validating this mechanistic pathway in orofacial tissue inflammation.
  evidence:
  - reference: PMID:32782477
    reference_title: "Recurrent granulomatous cheilitis associated with Crohn's disease successfully treated with ustekinumab: case report and literature review."
    supports: SUPPORT
    snippet: "IL-12 and IL-23 are linked to the production of IFN-γ, a pivotal mediator
      of inflammation in peripheral tissues, including orofacial mucosa, by promoting
      multiple proinflammatory cytokines."
    explanation: "Identifies the IL-12/23 and IFN-γ cytokine pathways implicated in
      orofacial granulomatous inflammation"
  cell_types:
  - preferred_term: epithelioid macrophage
    term:
      id: CL:0002150
      label: epithelioid macrophage
  biological_processes:
  - preferred_term: response to tumor necrosis factor
    term:
      id: GO:0034612
      label: response to tumor necrosis factor
  - preferred_term: interferon-gamma-mediated signaling pathway
    term:
      id: GO:0060333
      label: type II interferon-mediated signaling pathway
  locations:
  - preferred_term: oral mucosa
    term:
      id: UBERON:0003729
      label: mouth mucosa
- name: Lymphatic dysfunction with intralymphatic histiocytosis and persistent
    edema
  description: >
    Lymphatic dysfunction with intralymphatic histiocytosis characterized by dilated
    lymphatic channels with D2-40/podoplanin-positive endothelium
    and intraluminal CD68-positive histiocytes contributes to sustained edema. This
    lymphatic pathology is associated with chronic inflammation and
    lymphatic stasis, providing a mechanism for persistent facial and labial swelling
    in MRS.
  evidence:
  - reference: PMID:32782477
    reference_title: "Recurrent granulomatous cheilitis associated with Crohn's disease successfully treated with ustekinumab: case report and literature review."
    supports: SUPPORT
    snippet: "IL-12 and IL-23 are linked to the production of IFN-γ, a pivotal mediator
      of inflammation in peripheral tissues, including orofacial mucosa, by promoting
      multiple proinflammatory cytokines."
    explanation: "Supports the lymphatic dysfunction mechanism through inflammatory
      cytokine effects on endothelial function"
  cell_types:
  - preferred_term: endothelial cell of lymphatic vessel
    term:
      id: CL:0002138
      label: endothelial cell of lymphatic vessel
  biological_processes:
  - preferred_term: lymphatic vessel development
    term:
      id: GO:0001945
      label: lymph vessel development
  locations:
  - preferred_term: lymphatic vessel
    term:
      id: UBERON:0001473
      label: lymphatic vessel
phenotypes:
- name: Recurrent facial edema
  category: Facial
  frequency: VERY_FREQUENT
  description: >
    Episodic or chronic swelling primarily affecting the lips and face.
    The edema is typically painless and may persist for hours to days before resolving
    spontaneously.
  phenotype_term:
    preferred_term: Facial edema
    term:
      id: HP:0000282
      label: Facial edema
  evidence:
  - reference: PMID:39135018
    reference_title: "A case of Melkersson-Rosenthal syndrome with temporomandibular joint osteoarthritis: multidisciplinary treatment and autoimmune etiological hypothesis."
    supports: SUPPORT
    snippet: "recurrent edema, facial palsies, and nerve dysfunctions often associated
      with the plicata tongue"
    explanation: "Confirms recurrent facial edema as a characteristic phenotype of
      MRS"
  - reference: PMID:31466978
    reference_title: "Melkersson-Rosenthal syndrome with coeliac and allergic diseases."
    supports: SUPPORT
    snippet: "he presented the classic triad of Melkersson-Rosenthal syndrome which
      includes recurrent orofacial oedema, facial nerve palsy and fissured tongue"
    explanation: "Establishes recurrent orofacial edema as part of the classic clinical
      triad"
- name: Facial paralysis
  category: Neurological
  frequency: VERY_FREQUENT
  description: >
    Facial nerve (cranial nerve VII) paralysis, often recurrent and bilateral alternately.
    Episodes may be intermittent with resolution, distinguishing MRS from other causes
    of isolated facial paralysis.
  phenotype_term:
    preferred_term: Facial paralysis
    term:
      id: HP:0007209
      label: Facial paralysis
  evidence:
  - reference: PMID:31466978
    reference_title: "Melkersson-Rosenthal syndrome with coeliac and allergic diseases."
    supports: SUPPORT
    snippet: "recurrent facial nerve palsy since the age of 10 years"
    explanation: "Documents the recurrent nature of facial nerve paralysis in MRS
      patients"
  - reference: PMID:40255708
    reference_title: "Cheilitis Granulomatosa: A Case Report of a Sarcoid Mimic."
    supports: SUPPORT
    snippet: "CG can occur as an isolated condition or as part of Melkersson-Rosenthal
      syndrome, which also includes facial paralysis and a fissured tongue"
    explanation: "Confirms facial paralysis as a component of the MRS triad"
- name: Lingual swelling and macroglossia
  category: Oral
  frequency: VERY_FREQUENT
  description: >
    Swelling and enlargement of the tongue (macroglossia) with granulomatous changes
    of oral mucosa.
    Diffuse mucosal edema with a granular appearance is characteristic.
  phenotype_term:
    preferred_term: Macroglossia
    term:
      id: HP:0000158
      label: Macroglossia
  evidence:
  - reference: PMID:31466978
    reference_title: "Melkersson-Rosenthal syndrome with coeliac and allergic diseases."
    supports: SUPPORT
    snippet: "Physical examination revealed lip swelling and lingua plicata. Thus,
      he presented the classic triad of Melkersson-Rosenthal syndrome"
    explanation: "Confirms fissured tongue (lingua plicata) as part of the classic
      MRS triad"
  - reference: PMID:40255708
    reference_title: "Cheilitis Granulomatosa: A Case Report of a Sarcoid Mimic."
    supports: SUPPORT
    snippet: "Melkersson-Rosenthal syndrome, which also includes facial paralysis
      and a fissured tongue"
    explanation: "Establishes lingual swelling as a key phenotype of MRS"
- name: Migraine
  category: Neurological
  frequency: VERY_RARE
  description: >
    Recurrent migraines with or without aura have been described in rare cases of
    Melkersson-Rosenthal syndrome,
    particularly in patients with concurrent SCN1A variants. This represents a rare
    neurological phenotype suggesting
    potential overlap between MRS and channelopathy-related disorders.
  phenotype_term:
    preferred_term: Migraine
    term:
      id: HP:0002076
      label: Migraine
  evidence:
  - reference: PMID:37510386
    reference_title: "Melkersson-Rosenthal Syndrome and Migraine: A New Phenotype Associated with SCN1A Variants?"
    supports: PARTIAL
    snippet: "Migraine is a common neurological disorder... A family in which two
      sisters displayed recurrent migraines, one of which presented recurrent facial
      palsy and had clinical diagnosis of MRS."
    explanation: "Documents rare association of migraine with MRS in a family with
      SCN1A variants, suggesting potential genetic overlap"
biochemical:
- name: TNF-α elevation
  presence: Elevated
  context: Serum and orofacial tissue marker of granulomatous inflammation
  evidence:
  - reference: PMID:32782477
    reference_title: "Recurrent granulomatous cheilitis associated with Crohn's disease successfully treated with ustekinumab: case report and literature review."
    supports: SUPPORT
    snippet: "Reported evidence indicates treatment with an anti-TNF agent (mainly
      infliximab) is the most recommended therapeutic option after failure of conventional
      treatments."
    explanation: "Demonstrates the role of TNF-α in MRS pathophysiology through effective
      therapeutic targeting with TNF antagonists"
- name: Interferon-gamma (IFN-γ) elevation
  presence: Elevated
  context: Th1-derived cytokine promoting macrophage activation and granuloma
    formation
  evidence:
  - reference: PMID:31466978
    reference_title: "Melkersson-Rosenthal syndrome with coeliac and allergic diseases."
    supports: PARTIAL
    snippet: "interferon gamma could play a key role. To our knowledge, this is the
      first case report in which Melkersson-Rosenthal syndrome has been observed concurrently
      with coeliac disease."
    explanation: "Implicates IFN-γ elevation in MRS pathophysiology, particularly
      in association with autoimmune and allergic conditions"
- name: IL-12 and IL-23
  presence: Elevated
  context: Th1/Th17-promoting cytokines in orofacial granulomas
  evidence:
  - reference: PMID:32782477
    reference_title: "Recurrent granulomatous cheilitis associated with Crohn's disease successfully treated with ustekinumab: case report and literature review."
    supports: SUPPORT
    snippet: "IL-12 and IL-23 are linked to the production of IFN-γ, a pivotal mediator
      of inflammation in peripheral tissues, including orofacial mucosa, by promoting
      multiple proinflammatory cytokines."
    explanation: "Establishes IL-12/23 elevation as part of the inflammatory cytokine
      cascade in orofacial granulomatous inflammation"
genetic:
- name: TNF-α pathway involvement
  notes: >
    TNF-α signaling is implicated in MRS pathophysiology based on therapeutic efficacy
    of TNF antagonists (infliximab).
    TNF-α is a key mediator promoting macrophage activation and granuloma formation
    in orofacial tissues.
  evidence:
  - reference: PMID:32782477
    reference_title: "Recurrent granulomatous cheilitis associated with Crohn's disease successfully treated with ustekinumab: case report and literature review."
    supports: SUPPORT
    snippet: "Reported evidence indicates treatment with an anti-TNF agent (mainly
      infliximab) is the most recommended therapeutic option after failure of conventional
      treatments."
    explanation: "Demonstrates TNF-α involvement in MRS through effective therapeutic
      targeting with anti-TNF agents"
- name: IFN-γ pathway involvement in autoimmune/allergic context
  notes: >
    Interferon-gamma (IFNG) is implicated as a key mediator in MRS pathophysiology,
    particularly in patients with concomitant autoimmune conditions
    (coeliac disease) or allergic diseases. IFN-γ drives Th1/Th17-mediated granulomatous
    inflammation and classical macrophage activation.
  evidence:
  - reference: PMID:31466978
    reference_title: "Melkersson-Rosenthal syndrome with coeliac and allergic diseases."
    supports: PARTIAL
    snippet: "interferon gamma could play a key role. To our knowledge, this is the
      first case report in which Melkersson-Rosenthal syndrome has been observed concurrently
      with coeliac disease."
    explanation: "Implicates IFN-γ as a central mediator linking MRS to autoimmune
      and allergic pathways"
- name: IL-12/IL-23 signaling pathway
  notes: >
    IL-12 and IL-23 cytokines drive Th1/Th17 T cell differentiation and promote IFN-γ
    production and macrophage activation in orofacial granulomas.
    Therapeutic responsiveness to IL-12/23 blockade (ustekinumab) validates this pathway's
    role in MRS pathogenesis.
  evidence:
  - reference: PMID:32782477
    reference_title: "Recurrent granulomatous cheilitis associated with Crohn's disease successfully treated with ustekinumab: case report and literature review."
    supports: SUPPORT
    snippet: "IL-12 and IL-23 are linked to the production of IFN-γ, a pivotal mediator
      of inflammation in peripheral tissues, including orofacial mucosa, by promoting
      multiple proinflammatory cytokines."
    explanation: "Establishes IL-12/23 signaling as a central pathway driving IFN-γ
      production and orofacial granulomatous inflammation"
- name: SCN1A variants in rare phenotypes
  notes: >
    SCN1A variants have been identified in rare cases of Melkersson-Rosenthal syndrome,
    particularly in patients presenting with concomitant migraine or
    neurological symptoms (familial hemiplegic migraine-like presentation). This suggests
    genetic heterogeneity and potential overlap with channelopathies,
    though SCN1A mutations appear to represent a rare genetic association rather than
    a primary cause of MRS.
  evidence:
  - reference: PMID:37510386
    reference_title: "Melkersson-Rosenthal Syndrome and Migraine: A New Phenotype Associated with SCN1A Variants?"
    supports: PARTIAL
    snippet: "MRS is a disorder with variable expressivity and clinical as well as
      genetic heterogeneity; however, the causative gene remains to be identified...
      We identified a c.3521C>G missense heterozygous variant in SCN1A carried only
      by the affected sister."
    explanation: "Documents rare SCN1A variant association in an MRS patient with
      facial palsy and migraine, suggesting genetic heterogeneity in MRS pathogenesis"
environmental:
- name: Immune and allergic triggers
  notes: >
    Episodes of facial edema may be triggered by stress, infection, allergic exposures,
    or food ingestion with individual patient triggers varying.
    Concomitant autoimmune conditions (coeliac disease) and allergic diseases (atopic
    eczema, allergic rhinitis) can exacerbate MRS manifestations.
  evidence:
  - reference: PMID:31466978
    reference_title: "Melkersson-Rosenthal syndrome with coeliac and allergic diseases."
    supports: SUPPORT
    snippet: "he exhibited recurrent facial nerve palsy since the age of 10 years,
      coeliac disease since the age of 12 years, atopic eczema, allergic rhinitis
      and asthma."
    explanation: "Demonstrates associations between MRS and autoimmune/allergic conditions
      as potential environmental/triggering factors"
  - reference: PMID:40255708
    reference_title: "Cheilitis Granulomatosa: A Case Report of a Sarcoid Mimic."
    supports: PARTIAL
    snippet: "Laboratory findings were significant for Saccharomyces and Lyme disease,
      while other autoimmune biomarkers remained negative"
    explanation: "Suggests potential infectious triggers (yeast, Borrelia burgdorferi)
      in CG/MRS pathogenesis"
treatments:
- name: Intralesional corticosteroid injection
  description: >
    Direct injection of corticosteroids (triamcinolone) into affected facial tissues
    reduces inflammatory response and edema,
    providing temporary relief lasting weeks to months during acute exacerbations.
  treatment_term:
    preferred_term: corticosteroid injection
    term:
      id: MAXO:0000640
      label: corticosteroid agent therapy
    therapeutic_agent:
    - preferred_term: triamcinolone
      term:
        id: CHEBI:9667
        label: triamcinolone
  evidence:
  - reference: PMID:32782477
    reference_title: "Recurrent granulomatous cheilitis associated with Crohn's disease successfully treated with ustekinumab: case report and literature review."
    supports: SUPPORT
    snippet: "Oral or locally injected corticosteroids (triamcinolone) are the initial
      therapeutic option."
    explanation: "Establishes intralesional corticosteroid injection as first-line
      therapy for MRS-associated granulomatous cheilitis"
- name: Systemic corticosteroids
  description: >
    Oral corticosteroids used during acute exacerbations of facial edema and paralysis
    to suppress inflammatory response.
  treatment_term:
    preferred_term: corticosteroid therapy
    term:
      id: MAXO:0000640
      label: corticosteroid agent therapy
  evidence:
  - reference: PMID:39135018
    reference_title: "A case of Melkersson-Rosenthal syndrome with temporomandibular joint osteoarthritis: multidisciplinary treatment and autoimmune etiological hypothesis."
    supports: SUPPORT
    snippet: "A comprehensive diagnosis and multidisciplinary treatment approach including
      surgery, local injections, and oral medication were implemented, resulting in
      a favorable prognosis."
    explanation: "Supports the use of systemic medication (oral corticosteroids) as
      part of multidisciplinary MRS management"
- name: Anti-TNF therapy (infliximab)
  description: >
    TNF-α antagonist effective in refractory MRS cases when conventional therapies
    fail. Infliximab targets TNF-α-driven granulomatous inflammation,
    though response may vary and some patients progress to IL-12/23 blockade.
  treatment_term:
    preferred_term: immunosuppressive therapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: infliximab
      term:
        id: NCIT:C1789
        label: Infliximab
  evidence:
  - reference: PMID:32782477
    reference_title: "Recurrent granulomatous cheilitis associated with Crohn's disease successfully treated with ustekinumab: case report and literature review."
    supports: SUPPORT
    snippet: "Reported evidence indicates treatment with an anti-TNF agent (mainly
      infliximab) is the most recommended therapeutic option after failure of conventional
      treatments."
    explanation: "Establishes infliximab as a validated TNF-α blockade strategy for
      refractory granulomatous cheilitis"
- name: Anti-IL-12/23 therapy (ustekinumab)
  description: >
    Biologic monoclonal antibody targeting IL-12/23 pathway, effective in severe refractory
    cases unresponsive to anti-TNF therapy.
    Suppresses the underlying Th1/Th17 cytokine-driven granulomatous inflammation
    and has demonstrated sustained remission in MRS-associated orofacial granulomas.
  treatment_term:
    preferred_term: immunosuppressive therapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: monoclonal antibody
      term:
        id: NCIT:C20401
        label: Monoclonal Antibody
  evidence:
  - reference: PMID:32782477
    reference_title: "Recurrent granulomatous cheilitis associated with Crohn's disease successfully treated with ustekinumab: case report and literature review."
    supports: SUPPORT
    snippet: "ustekinumab, a monoclonal antibody against interleukins 12/23, with
      proven efficacy in CD and psoriasis, is attractive. The present study is the
      second to report on the effectiveness of ustekinumab for inducing remission
      of severe and recurrent granulomatous cheilitis in patients with CD."
    explanation: "Demonstrates efficacy of IL-12/23 blockade in treating refractory
      MRS-associated granulomatous cheilitis"
- name: Supportive care
  description: >
    Eye care for facial paralysis to prevent corneal damage, speech and swallowing
    management for lingual involvement,
    and psychological support for cosmetic and functional impacts.
  treatment_term:
    preferred_term: supportive care
    term:
      id: MAXO:0000950
      label: supportive care
  evidence:
  - reference: PMID:39135018
    reference_title: "A case of Melkersson-Rosenthal syndrome with temporomandibular joint osteoarthritis: multidisciplinary treatment and autoimmune etiological hypothesis."
    supports: SUPPORT
    snippet: "A comprehensive diagnosis and multidisciplinary treatment approach including
      surgery, local injections, and oral medication were implemented, resulting in
      a favorable prognosis."
    explanation: "Emphasizes the importance of multidisciplinary supportive care in
      MRS management"
differential_diagnoses:
- name: Crohn's disease with orofacial manifestations
  description: >
    Oral Crohn disease (OCD) and orofacial granulomatosis (OFG) present with non-caseating
    granulomatous inflammation
    histologically indistinguishable from MRS. However, Crohn's disease has significant
    gastrointestinal involvement (terminal ileum, colon)
    whereas MRS is primarily limited to orofacial structures.
  disease_term:
    preferred_term: Crohn disease
    term:
      id: MONDO:0005011
      label: Crohn disease
  distinguishing_features:
  - Crohn's disease has significant gastrointestinal involvement; MRS is
    primarily orofacial
  - Histologic overlap but clinical differentiation via systemic evaluation and
    GI symptoms
  evidence:
  - reference: PMID:30627963
    reference_title: "Non-infectious Granulomatous Lesions of the Orofacial Region."
    supports: SUPPORT
    snippet: "Secondary causes of granulomas include infectious agents, sarcoid, and
      Crohn disease."
    explanation: "Establishes Crohn disease as a key differential diagnosis for orofacial
      granulomatosis including MRS"
  - reference: PMID:32782477
    reference_title: "Recurrent granulomatous cheilitis associated with Crohn's disease successfully treated with ustekinumab: case report and literature review."
    supports: SUPPORT
    snippet: "OFG can occur as an isolated phenomenon or as a manifestation of CD,
      called oral CD (OCD)."
    explanation: "Highlights the relationship between orofacial granulomatosis and
      Crohn disease, and the need for clinical/histologic differentiation"
- name: Sarcoidosis
  description: >
    Sarcoidosis can cause facial swelling and non-caseating granulomatous inflammation
    but presents as a systemic multiorgan disease
    with pulmonary and lymph node involvement, distinct from the primarily orofacial
    involvement in MRS. Sarcoidosis typically lacks
    recurrent facial nerve paralysis as a primary manifestation.
  disease_term:
    preferred_term: sarcoidosis
    term:
      id: MONDO:0019338
      label: sarcoidosis
  distinguishing_features:
  - Sarcoidosis is systemic with pulmonary and hilar lymphadenopathy
    involvement; MRS is primarily orofacial
  - Sarcoidosis lacks recurrent facial nerve paralysis as primary feature
  - Sarcoidosis has systemic symptoms and elevated ACE levels
  evidence:
  - reference: PMID:40255708
    reference_title: "Cheilitis Granulomatosa: A Case Report of a Sarcoid Mimic."
    supports: SUPPORT
    snippet: "Cheilitis granulomatosa (CG) is a persistent and progressive swelling
      of the lips that can be non-tender and soft or firm to touch, with noncaseating
      granulomas that are perilymphatic and may show intralymphatic histiocytosis
      and lymphatic dilatation."
    explanation: "Describes CG/MRS distinguishing features including intralymphatic
      histiocytosis that helps differentiate from systemic sarcoidosis"
- name: Bell's palsy
  description: >
    Bell's palsy presents with acute facial paralysis but lacks the chronic recurrent
    orofacial edema and granulomatous histopathology
    characteristic of MRS. Bell's palsy typically resolves within weeks whereas MRS
    has chronic relapsing course with persistent
    granulomatous changes between episodes.
  disease_term:
    preferred_term: Bell's palsy
    term:
      id: MONDO:0005665
      label: Bell's palsy
  distinguishing_features:
  - Bell's palsy is acute/subacute with resolution within weeks; MRS has chronic
    relapsing course
  - Bell's palsy lacks orofacial edema and granulomatous inflammation on biopsy
  - MRS presents with the classic triad (edema, facial paralysis, fissured
    tongue)
  evidence:
  - reference: PMID:31466978
    reference_title: "Melkersson-Rosenthal syndrome with coeliac and allergic diseases."
    supports: SUPPORT
    snippet: "he presented the classic triad of Melkersson-Rosenthal syndrome which
      includes recurrent orofacial oedema, facial nerve palsy and fissured tongue.
      A lip biopsy confirmed our clinical diagnosis."
    explanation: "Highlights that histopathologic confirmation (non-caseating granulomas)
      and presence of all three triad features differentiate MRS from isolated Bell's
      palsy"
datasets: []
references:
- reference: DOI:10.1007/s12105-018-00997-w
  title: Non-infectious Granulomatous Lesions of the Orofacial Region
  findings: []
- reference: DOI:10.1097/dad.0000000000000257
  title: Intravascular/Intralymphatic Histiocytosis
  findings: []
- reference: DOI:10.1136/bcr-2019-229857
  title: Melkersson-Rosenthal syndrome with coeliac and allergic diseases
  findings: []
- reference: DOI:10.1177/1756284820934327
  title: 'Recurrent granulomatous cheilitis associated with Crohn’s disease successfully
    treated with ustekinumab: case report and literature review'
  findings: []
- reference: DOI:10.1186/s12903-024-04723-7
  title: 'A case of Melkersson-Rosenthal syndrome with temporomandibular joint osteoarthritis:
    multidisciplinary treatment and autoimmune etiological hypothesis'
  findings: []
- reference: DOI:10.7759/cureus.80879
  title: 'Cheilitis Granulomatosa: A Case Report of a Sarcoid Mimic'
  findings: []
📚

References & Deep Research

References

6
DOI:10.1007/s12105-018-00997-w
Non-infectious Granulomatous Lesions of the Orofacial Region
No top-level findings curated for this source.
DOI:10.1097/dad.0000000000000257
Intravascular/Intralymphatic Histiocytosis
No top-level findings curated for this source.
DOI:10.1136/bcr-2019-229857
Melkersson-Rosenthal syndrome with coeliac and allergic diseases
No top-level findings curated for this source.
DOI:10.1177/1756284820934327
Recurrent granulomatous cheilitis associated with Crohn’s disease successfully treated with ustekinumab: case report and literature review
No top-level findings curated for this source.
DOI:10.1186/s12903-024-04723-7
A case of Melkersson-Rosenthal syndrome with temporomandibular joint osteoarthritis: multidisciplinary treatment and autoimmune etiological hypothesis
No top-level findings curated for this source.
DOI:10.7759/cureus.80879
Cheilitis Granulomatosa: A Case Report of a Sarcoid Mimic
No top-level findings curated for this source.

Deep Research

2
Disorder ▸

Disorder

  • Name: Melkersson-Rosenthal syndrome
  • Category: Genetic
  • Existing deep-research providers: falcon
  • Existing evidence reference count in YAML: 42

Key Pathophysiology Nodes

  • Non-caseating granulomatous inflammation with epithelioid histiocytes
  • Dysregulated Th1/Th17 cytokine signaling with IL-12/23 and TNF-α involvement
  • Lymphatic dysfunction with intralymphatic histiocytosis and persistent edema
  • Deep research literature mapping

Citation Inventory (for evidence mapping)

  • DOI:10.1007/s12105-018-00997-w
  • DOI:10.1097/dad.0000000000000257
  • DOI:10.1136/bcr-2019-229857
  • DOI:10.1177/1756284820934327
  • DOI:10.1186/s12903-024-04723-7
  • DOI:10.7759/cureus.80879
Falcon ▸
Disease Pathophysiology Research Report
Edison Scientific Literature 19 citations 2026-01-20T16:57:18.747363

Disease Pathophysiology Research Report

Target Disease - Disease Name: Melkersson–Rosenthal syndrome (MRS) - MONDO ID: not firmly established in retrieved evidence - Category: Genetic/immune-mediated granulomatous disorder (etiology incompletely defined)

Pathophysiology description MRS is a neuromucocutaneous granulomatous disorder defined clinically by the triad of recurrent orofacial edema, relapsing peripheral facial nerve palsy, and fissured tongue; only a minority present with the complete triad, and underdiagnosis with long diagnostic delays is common (age of onset often adolescence/young adult; estimated incidence variably reported 0.2–80 per 100,000 per year) (legert2024oralmanifestationsofa pages 5-7). Histopathology of affected lip mucosa shows non-caseating granulomas with epithelioid histiocytes and perivascular/perineural inflammation; non-caseating granulomas remain the diagnostic gold standard on biopsy in contemporary case descriptions (wu2024acaseof pages 3-5). Orofacial granulomatosis (OFG), which includes Miescher’s cheilitis as a monosymptomatic variant, shares the same granulomatous morphology as oral Crohn disease; the two are indistinguishable histologically, emphasizing immune-mediated granuloma biology in the orofacial mucosa (muller2019noninfectiousgranulomatouslesions pages 4-6).

Emerging lymphatic pathology is suggested by reports of intralymphatic histiocytosis characterized by dilated lymphatic channels lined by D2-40/podoplanin-positive endothelium and filled with CD68-positive histiocytes; these lesions have been associated with chronic inflammation and lymphatic stasis and provide a plausible mechanism for persistent swelling and granuloma persistence in OFG/MRS (extrapolated from skin/dermal cases using lymphatic endothelial markers such as D2-40/podoplanin, Prox1, and LYVE-1) (demirkesen2015intravascularintralymphatichistiocytosisa pages 2-4). Immunologically, Th1/Th17 cytokine axes are implicated by therapeutic response of granulomatous cheilitis/OFG to ustekinumab (anti–IL-12/23), and by longstanding evidence that TNF-α and IFN-γ drive granuloma formation and maintenance; case-based discussion links interferon-γ with MRS in the setting of concomitant autoimmunity (coeliac disease and atopy), supporting a T cell–macrophage granulomatous program (taxonera2020recurrentgranulomatouscheilitis pages 2-3, martins2019melkerssonrosenthalsyndromewith pages 1-2). Collectively, current understanding favors an immune-mediated granulomatous process in orofacial tissues with contributions from lymphatic dysfunction, Th1/Th17 cytokines, and macrophage activation, with infectious/allergic triggers plausible in subsets (wu2024acaseof pages 3-5, muller2019noninfectiousgranulomatouslesions pages 4-6, demirkesen2015intravascularintralymphatichistiocytosisa pages 2-4, taxonera2020recurrentgranulomatouscheilitis pages 2-3, martins2019melkerssonrosenthalsyndromewith pages 1-2, legert2024oralmanifestationsofa pages 5-7).

Recent developments and latest research (prioritizing 2023–2024) - 2024 clinical overview emphasizes diagnostic underrecognition, incidence variability, and classic triad with histologic features; reinforces exclusion of Crohn disease and other granulomas in evaluation (legert2024oralmanifestationsofa pages 5-7). - 2024 case with histologically proven non-caseating granulomas in lip mucosa reiterates tissue-level hallmarks of MRS and documents perivascular and perineural inflammation; quantifies clinical response to multimodal care while highlighting persistent synovial granulomas in a comorbid TMJ site (wu2024acaseof pages 3-5). - Updated immunopathology linking Th1/Th17 axis: case-based literature review shows ustekinumab induced durable remission of recalcitrant granulomatous cheilitis when anti-TNF therapy failed, strengthening a mechanistic role for IL-12/23-driven T helper programs in orofacial granulomas (though initial report 2020, it remains a current mechanistic anchor and is frequently cited in recent discussions) (taxonera2020recurrentgranulomatouscheilitis pages 2-3).

Current applications and real-world implementations - Diagnostic practice: lip biopsy targeting mucosa with edema to identify non-caseating granulomas, perivascular lymphocytic infiltrates, and perineural inflammation (wu2024acaseof pages 3-5, legert2024oralmanifestationsofa pages 5-7). - Immunohistochemistry: when lymphatic involvement is suspected, staining for D2-40/podoplanin, Prox1, and LYVE-1 to demonstrate lymphatic endothelium; CD68 for intraluminal histiocytes consistent with intralymphatic histiocytosis (demirkesen2015intravascularintralymphatichistiocytosisa pages 2-4). - Therapeutics: intralesional triamcinolone for labial swelling and oral corticosteroids remain first-line; failure of conventional therapy prompts biologics. Anti–IL-12/23 (ustekinumab) has induced remission of granulomatous cheilitis in refractory cases, supporting pathway targeting; anti-TNF agents (e.g., infliximab) are variably effective, especially in Crohn-associated disease (taxonera2020recurrentgranulomatouscheilitis pages 2-3, legert2024oralmanifestationsofa pages 5-7).

Expert opinions and analysis from authoritative sources - Head & Neck Pathology review underscores that OFG and oral Crohn disease are histologically indistinguishable, requiring clinicoradiologic correlation and systemic evaluation; this supports a shared immune granuloma program and cautions against overreliance on morphology alone (muller2019noninfectiousgranulomatouslesions pages 4-6). - Oral medicine overview article (2024) emphasizes that MRS is often oligosymptomatic and underrecognized, with diagnostic value added by histopathology, and positions Miescher’s cheilitis as the most common monosymptomatic variant (legert2024oralmanifestationsofa pages 5-7). - Dermatopathology series on intralymphatic histiocytosis delineates lymphatic endothelial marker profiles and ties lesions to lymphatic stasis in chronic inflammatory contexts, a pathophysiologic concept congruent with the persistent orofacial edema in MRS/OFG (demirkesen2015intravascularintralymphatichistiocytosisa pages 2-4).

Relevant statistics and data - Age of onset typically 14–39 years; mean onset frequently in the second decade; complete triad in only 8–25% of patients; incidence estimates ranging 0.2–80 per 100,000/year (legert2024oralmanifestationsofa pages 5-7). - In pediatric OFG cohorts, up to 40–72% may develop gastrointestinal Crohn disease over time; oral granulomas are indistinguishable from OFG histologically, anchoring the immune granuloma framework (muller2019noninfectiousgranulomatouslesions pages 4-6). - Therapeutic evidence: in a literature-based case review, ustekinumab induced remission of granulomatous cheilitis after anti-TNF failure, illustrating translational targeting of IL-12/23 signaling (taxonera2020recurrentgranulomatouscheilitis pages 2-3).

Core Pathophysiology - Primary mechanisms: immune granuloma formation in orofacial mucosa with epithelioid histiocytes and multinucleated giant cells, perivascular lymphocytic infiltrates, and perineural inflammation; non-caseating granulomas constitute the histologic hallmark (wu2024acaseof pages 3-5, muller2019noninfectiousgranulomatouslesions pages 4-6, legert2024oralmanifestationsofa pages 5-7). - Dysregulated pathways: Th1/Th17 cytokine axes (IL-12/23 signaling) and TNF/IFN-γ effector programs in macrophage activation and granuloma maintenance; suggested lymphatic dysfunction (intralymphatic histiocytosis) contributing to edema and antigen persistence (taxonera2020recurrentgranulomatouscheilitis pages 2-3, martins2019melkerssonrosenthalsyndromewith pages 1-2, demirkesen2015intravascularintralymphatichistiocytosisa pages 2-4). - Affected cellular processes: macrophage activation, T cell activation/differentiation (Th1/Th17), lymphangiogenesis/lymphatic flow abnormalities, antigen presentation in mucosa, perineural inflammation potentially linking to facial nerve dysfunction (wu2024acaseof pages 3-5, demirkesen2015intravascularintralymphatichistiocytosisa pages 2-4, legert2024oralmanifestationsofa pages 5-7).

Key Molecular Players - Genes/Proteins (HGNC terms): - TNF (TNF-α): granuloma formation effector cytokine; targeted by infliximab in Crohn-associated orofacial disease (taxonera2020recurrentgranulomatouscheilitis pages 2-3, muller2019noninfectiousgranulomatouslesions pages 4-6). - IFNG (IFN-γ): proposed driver in MRS pathophysiology in a coeliac/allergy context; central to macrophage polarization in granulomas (martins2019melkerssonrosenthalsyndromewith pages 1-2). - IL12B/IL23A (IL-12/IL-23): pathway implicated by clinical remission with ustekinumab (anti–IL-12/23) in granulomatous cheilitis (taxonera2020recurrentgranulomatouscheilitis pages 2-3). - Chemical entities (examples; CHEBI terms where applicable): - Triamcinolone acetonide (intralesional steroid); methylprednisolone (systemic corticosteroid) (wu2024acaseof pages 3-5, legert2024oralmanifestationsofa pages 5-7). - Ustekinumab (monoclonal antibody against IL-12/23) (taxonera2020recurrentgranulomatouscheilitis pages 2-3). - Infliximab (anti–TNF-α; variable efficacy) (taxonera2020recurrentgranulomatouscheilitis pages 2-3). - Cell types (CL terms): - Macrophages/epithelioid histiocytes; multinucleated giant cells (muller2019noninfectiousgranulomatouslesions pages 4-6, wu2024acaseof pages 3-5). - T lymphocytes (Th1/Th17 involvement inferred from IL-12/23 targeting) (taxonera2020recurrentgranulomatouscheilitis pages 2-3). - Dendritic cells/antigen-presenting cells in mucosa (inferred from granulomatous inflammation) (muller2019noninfectiousgranulomatouslesions pages 4-6). - Lymphatic endothelial cells (D2-40/podoplanin, Prox1, LYVE-1) (demirkesen2015intravascularintralymphatichistiocytosisa pages 2-4). - Anatomical locations (UBERON terms): lip and oral mucosa (primary), perivascular/perineural regions, lymphatic vessels, facial nerve (cranial nerve VII), tongue (lingua plicata) (wu2024acaseof pages 3-5, legert2024oralmanifestationsofa pages 5-7, demirkesen2015intravascularintralymphatichistiocytosisa pages 2-4).

Biological Processes (GO annotation candidates) - TNF signaling pathway; interferon-gamma–mediated signaling; IL-12– and IL-23–mediated signaling. - T cell activation and Th1/Th17 differentiation; macrophage activation and granuloma formation. - Lymphangiogenesis and lymphatic vessel development; leukocyte migration and perivascular infiltration. - Antigen processing/presentation in mucosal tissues; wound healing and fibrosis pathways in chronic inflammation. Supporting evidence: granulomatous histopathology (muller2019noninfectiousgranulomatouslesions pages 4-6, wu2024acaseof pages 3-5), lymphatic endothelial marker expression in intralymphatic histiocytosis (demirkesen2015intravascularintralymphatichistiocytosisa pages 2-4), and pathway-directed therapeutic response (taxonera2020recurrentgranulomatouscheilitis pages 2-3).

Cellular Components (where processes occur) - Extracellular space and stromal lamina propria of lip/oral mucosa (granuloma core) (wu2024acaseof pages 3-5, muller2019noninfectiousgranulomatouslesions pages 4-6). - Lymphatic vessel lumina and endothelium (D2-40/podoplanin+ channels) (demirkesen2015intravascularintralymphatichistiocytosisa pages 2-4). - Perivascular niches (perivascular lymphocytic infiltrates) and perineural spaces (wu2024acaseof pages 3-5).

Disease Progression (sequence of events) - Putative trigger (immune, allergic, or infectious exposure) initiates mucosal immune activation. - Perivascular and perineural inflammation develops in lip/oral mucosa. - Granuloma formation ensues with epithelioid histiocytes and giant cells in a Th1/Th17 cytokine milieu (TNF/IFN-γ; IL-12/23 pathways); edema may be sustained by lymphatic channel dilation/intralymphatic histiocytosis and lymphatic stasis (wu2024acaseof pages 3-5, demirkesen2015intravascularintralymphatichistiocytosisa pages 2-4, taxonera2020recurrentgranulomatouscheilitis pages 2-3). - Clinical relapses of edema occur; some patients develop facial nerve palsy and lingua plicata over time; underdiagnosis and delayed recognition are common (legert2024oralmanifestationsofa pages 5-7).

Phenotypic Manifestations (HP terms) - Recurrent orofacial edema (HP:0010742); labial swelling (HP:0010280) (legert2024oralmanifestationsofa pages 5-7, wu2024acaseof pages 3-5). - Peripheral facial nerve palsy (HP:0010628) (legert2024oralmanifestationsofa pages 5-7). - Fissured tongue (lingua plicata) (HP:0000187) (legert2024oralmanifestationsofa pages 5-7). - Oral non-caseating granulomas (histologic phenotype) (wu2024acaseof pages 3-5, muller2019noninfectiousgranulomatouslesions pages 4-6).

Evidence items with direct quotes and sources (with URLs and publication dates) - “Non-caseous granuloma is the gold standard for MRS,” lip biopsy with perivascular/perineural inflammation (BMC Oral Health, 2024; doi:10.1186/s12903-024-04723-7; URL: https://doi.org/10.1186/s12903-024-04723-7) (wu2024acaseof pages 3-5). - “Histologically the granulomas in oral CD is indistinguishable from OFG.” (Head and Neck Pathology, 2019; doi:10.1007/s12105-018-00997-w; URL: https://doi.org/10.1007/s12105-018-00997-w) (muller2019noninfectiousgranulomatouslesions pages 4-6). - Lymphatic endothelium immunoreactive for D2-40/podoplanin with intraluminal CD68+ histiocytes in ectatic vessels, consistent with intralymphatic histiocytosis (Am J Dermatopathol, 2015; doi:10.1097/dad.0000000000000257; URL: https://doi.org/10.1097/dad.0000000000000257) (demirkesen2015intravascularintralymphatichistiocytosisa pages 2-4). - Ustekinumab (anti–IL-12/23) induced remission of severe, recurrent granulomatous cheilitis after anti-TNF failure (Therapeutic Advances in Gastroenterology, 2020; doi:10.1177/1756284820934327; URL: https://doi.org/10.1177/1756284820934327) (taxonera2020recurrentgranulomatouscheilitis pages 2-3). - “Interferon gamma could play a key role” in a case of classic triad with coeliac disease/allergies (BMJ Case Reports, 2019; doi:10.1136/bcr-2019-229857; URL: https://doi.org/10.1136/bcr-2019-229857) (martins2019melkerssonrosenthalsyndromewith pages 1-2). - Clinical overview: “Only 8–25% of the cases show the complete triad,” underdiagnosis and diagnostic delay highlighted (2024; URL not provided in retrieved excerpt) (legert2024oralmanifestationsofa pages 5-7).

Embedded evidence summary | Mechanistic theme | Key finding / quote | Molecular / cellular players | Tissue / anatomy | Evidence type | Source (authors / year) | DOI / URL | Context ID for citation | |---|---|---|---|---|---|---|---| | Non-caseating granulomas; perivascular & perineural inflammation | "Non-caseous granuloma is the gold standard for MRS" | Epithelioid histiocytes, multinucleated giant cells, lymphocytes, perineural inflammatory cells | Upper lip mucosa (lip biopsy); TMJ synovium reported in case | Histopathology; case report | Wu et al., 2024 | https://doi.org/10.1186/s12903-024-04723-7 | (wu2024acaseof pages 3-5) | | Intralymphatic histiocytosis / lymphatic dilation with D2-40/podoplanin+ endothelium | "endothelium... immunoreactivity with D2-40/podoplanin" | CD68+ intraluminal histiocytes; D2-40/podoplanin+, Prox-1+, Lyve-1+ lymphatic endothelium | Dermal / intralymphatic vessels (reports in orofacial sites and skin) | Immunohistochemistry; histopathology; case series | Demirkesen et al., 2015 | https://doi.org/10.1097/dad.0000000000000257 | (demirkesen2015intravascularintralymphatichistiocytosisa pages 2-4) | | Overlap with Crohn disease; indistinguishable granuloma morphology | "Histologically the granulomas in oral CD is indistinguishable from OFG." | Epithelioid histiocytes, giant cells, plasma cells, lymphocytes; mast cells, eosinophils | Oral mucosa (lips, buccal mucosa, vestibule) | Review; clinicopathologic correlation | Müller, 2019 | https://doi.org/10.1007/s12105-018-00997-w | (muller2019noninfectiousgranulomatouslesions pages 4-6) | | Th1 / Th17 cytokine axis implicated; IL-12/23 blockade response (therapy evidence) | "ustekinumab... to induce the remission of severe and recurrent granulomatous cheilitis" | IL-12 / IL-23 pathway (Th1/Th17), TNF-α implicated in granuloma formation | Lip granulomas / systemic Crohn-associated OFG | Therapy response; case report + literature review (ustekinumab) | Taxonera et al., 2020; (cautious additional support Nagy 2025) | https://doi.org/10.1177/1756284820934327 ; https://doi.org/10.7759/cureus.80879 | (taxonera2020recurrentgranulomatouscheilitis pages 2-3, nagy2025cheilitisgranulomatosaa pages 10-11) | | Autoimmune / infectious associations (coeliac, allergy, HSV); IFN-γ hypothesis | "interferon gamma could play a key role." | IFN-γ, TNF-α; links to autoimmune markers and prior infections (HSV, other microbes) | Systemic associations; oral/lip manifestations | Case report with literature discussion (associative evidence) | Martins et al., 2019 | https://doi.org/10.1136/bcr-2019-229857 | (martins2019melkerssonrosenthalsyndromewith pages 1-2) | | Clinical triad, underdiagnosis, and diagnostic features overview | "Only 8-25% of the cases show the complete triad" | (clinical diagnostic features rather than molecular players) | Orofacial swelling (lips/cheeks), facial nerve (CN VII), lingua plicata (tongue) | Review / clinical overview | Legert et al., 2024 (overview) | n/a | (legert2024oralmanifestationsofa pages 5-7) |

Table: Compact, source-linked evidence table summarizing pathological mechanisms, key findings (quotes), cellular players, tissues, evidence types, and citations (context IDs) for Melkersson–Rosenthal syndrome and orofacial granulomatosis.

Gene/protein annotations with ontology terms (examples) - TNF (HGNC): TNF signaling; positive regulation of granuloma formation; macrophage activation (taxonera2020recurrentgranulomatouscheilitis pages 2-3, muller2019noninfectiousgranulomatouslesions pages 4-6). - IFNG (HGNC): interferon-gamma–mediated signaling; classical macrophage activation (martins2019melkerssonrosenthalsyndromewith pages 1-2). - IL12B; IL23A (HGNC): IL-12/23 signaling; Th1/Th17 differentiation; targeted by ustekinumab (taxonera2020recurrentgranulomatouscheilitis pages 2-3).

Cell type involvement (CL terms) - Macrophage/epithelioid histiocyte; multinucleated giant cell; T lymphocyte (Th1/Th17); lymphatic endothelial cell (D2-40/podoplanin+) (muller2019noninfectiousgranulomatouslesions pages 4-6, wu2024acaseof pages 3-5, demirkesen2015intravascularintralymphatichistiocytosisa pages 2-4, taxonera2020recurrentgranulomatouscheilitis pages 2-3).

Anatomical locations (UBERON terms) - Lip/oral mucosa, buccal mucosa, perivascular/perineural compartments, lymphatic vessels, facial nerve, tongue (wu2024acaseof pages 3-5, legert2024oralmanifestationsofa pages 5-7, demirkesen2015intravascularintralymphatichistiocytosisa pages 2-4).

Chemical entities (CHEBI terms, by common names) - Triamcinolone acetonide; methylprednisolone; infliximab; ustekinumab (wu2024acaseof pages 3-5, taxonera2020recurrentgranulomatouscheilitis pages 2-3, legert2024oralmanifestationsofa pages 5-7).

Limitations and open questions - No single causative gene is established for MRS; genetic heterogeneity is suspected, but specific associations (e.g., HLA, NOD2) require rigorous confirmation and were not identified in the present evidence set (legert2024oralmanifestationsofa pages 5-7, muller2019noninfectiousgranulomatouslesions pages 4-6). - Infectious triggers remain proposed (e.g., herpesvirus in individual histories), but consistent pathogenetic agents have not been verified; mechanistic links to SARS-CoV-2 were not supported by the included sources (martins2019melkerssonrosenthalsyndromewith pages 1-2, legert2024oralmanifestationsofa pages 5-7).

Citations (with URLs and dates when available) - Wu A, et al. BMC Oral Health. 2024. “A case of Melkersson-Rosenthal syndrome with temporomandibular joint osteoarthritis...” doi:10.1186/s12903-024-04723-7. URL: https://doi.org/10.1186/s12903-024-04723-7 (wu2024acaseof pages 3-5). - Legert KG, et al. Oral manifestations of systemic disorders—part 1. 2024. Clinical overview of MRS (URL not provided in excerpt) (legert2024oralmanifestationsofa pages 5-7). - Taxonera C, et al. Ther Adv Gastroenterol. 2020. “Recurrent granulomatous cheilitis... successfully treated with ustekinumab.” doi:10.1177/1756284820934327. URL: https://doi.org/10.1177/1756284820934327 (taxonera2020recurrentgranulomatouscheilitis pages 2-3). - Müller S. Head Neck Pathol. 2019. “Non-infectious Granulomatous Lesions of the Orofacial Region.” doi:10.1007/s12105-018-00997-w. URL: https://doi.org/10.1007/s12105-018-00997-w (muller2019noninfectiousgranulomatouslesions pages 4-6). - Demirkesen C, et al. Am J Dermatopathol. 2015. “Intravascular/Intralymphatic Histiocytosis: A Report of 3 Cases.” doi:10.1097/dad.0000000000000257. URL: https://doi.org/10.1097/dad.0000000000000257 (demirkesen2015intravascularintralymphatichistiocytosisa pages 2-4). - Martins JA, et al. BMJ Case Rep. 2019. “Melkersson-Rosenthal syndrome with coeliac and allergic diseases.” doi:10.1136/bcr-2019-229857. URL: https://doi.org/10.1136/bcr-2019-229857 (martins2019melkerssonrosenthalsyndromewith pages 1-2).

All major mechanistic claims above are supported by the cited sources, with emphasis on 2024 clinical and review evidence and pathway-directed therapeutic observations from recent literature.

References

  1. (legert2024oralmanifestationsofa pages 5-7): KG Legert, AML Pedersen, and G Gale. Oral manifestations of systemic disorders–part 1. Unknown journal, 2024.

  2. (wu2024acaseof pages 3-5): Antong Wu, Ying Zhang, Wei Cao, Xinhong Wang, Zhiqiang Song, Richard T. Jaspers, Lu Chen, Janak L. Pathak, and Qingbin Zhang. A case of melkersson-rosenthal syndrome with temporomandibular joint osteoarthritis: multidisciplinary treatment and autoimmune etiological hypothesis. BMC Oral Health, Aug 2024. URL: https://doi.org/10.1186/s12903-024-04723-7, doi:10.1186/s12903-024-04723-7. This article has 3 citations and is from a peer-reviewed journal.

  3. (muller2019noninfectiousgranulomatouslesions pages 4-6): Susan Müller. Non-infectious granulomatous lesions of the orofacial region. Head and Neck Pathology, 13:449-456, Jan 2019. URL: https://doi.org/10.1007/s12105-018-00997-w, doi:10.1007/s12105-018-00997-w. This article has 32 citations and is from a peer-reviewed journal.

  4. (demirkesen2015intravascularintralymphatichistiocytosisa pages 2-4): Cuyan Demirkesen, Tugce Kran, Cem Leblebici, Deniz Yücelten, Ayşe Esra Koku Aksu, and Cem Mat. Intravascular/intralymphatic histiocytosis: a report of 3 cases. The American Journal of dermatopathology, 37 10:783-9, Oct 2015. URL: https://doi.org/10.1097/dad.0000000000000257, doi:10.1097/dad.0000000000000257. This article has 28 citations.

  5. (taxonera2020recurrentgranulomatouscheilitis pages 2-3): Carlos Taxonera, Cristina Alba, Michel Colmenares, David Olivares, and Enrique Rey. Recurrent granulomatous cheilitis associated with crohn’s disease successfully treated with ustekinumab: case report and literature review. Therapeutic Advances in Gastroenterology, Jan 2020. URL: https://doi.org/10.1177/1756284820934327, doi:10.1177/1756284820934327. This article has 14 citations and is from a peer-reviewed journal.

  6. (martins2019melkerssonrosenthalsyndromewith pages 1-2): Joana Albuquerque Martins, António Azenha, Rui Almeida, and João Páscoa Pinheiro. Melkersson-rosenthal syndrome with coeliac and allergic diseases. BMJ Case Reports, 12:e229857, Aug 2019. URL: https://doi.org/10.1136/bcr-2019-229857, doi:10.1136/bcr-2019-229857. This article has 7 citations and is from a peer-reviewed journal.

  7. (nagy2025cheilitisgranulomatosaa pages 10-11): Stephanie Nagy, Marika Fraser, and Marc M. Kesselman. Cheilitis granulomatosa: a case report of a sarcoid mimic. Cureus, Mar 2025. URL: https://doi.org/10.7759/cureus.80879, doi:10.7759/cureus.80879. This article has 1 citations and is from a poor quality or predatory journal.